Related by context. All words. (Click for frequent words.) 72 urothelial carcinoma 70 gastric adenocarcinoma 70 metastatic adenocarcinoma 70 papillary carcinoma 70 prostate carcinoma 69 anaplastic 69 mucinous 69 fallopian tube carcinoma 68 intestinal metaplasia 68 gastrointestinal stromal tumor 68 papillary renal cell carcinoma 68 GISTs 68 ductal lobular 68 paragangliomas 68 leiomyosarcoma 68 Adenomas 68 squamous carcinoma 68 pulmonary metastases 68 Hurthle cell 67 epithelial tumors 67 metaplasia 67 carcinoid tumors 67 cervical lymph nodes 67 papillary thyroid carcinoma 67 MALT lymphoma 67 Papillary 67 allograft rejection 67 neoplasias 67 liver metastasis 67 carcinoid 67 prostate carcinomas 67 neoplastic lesions 67 adenomatous 66 malignant ascites 66 neoplasm 66 breast carcinomas 66 leiomyomas 66 carcinoids 66 PNET 66 metastatic bladder 66 histological subtype 66 peritoneal carcinomatosis 66 bile duct cancers 66 glomerulonephritis 66 hamartomas 66 fibroma 66 cholangiocarcinoma 66 nonsmall cell lung cancer 66 pancreatic adenocarcinoma 66 pleomorphic 66 hepatocellular carcinomas 66 colorectal carcinoma 66 lymphadenopathy 66 metastatic gastric 66 bronchogenic carcinoma 65 metastatic colorectal 65 epithelioid 65 Carcinoma 65 fallopian tube cancers 65 grade cervical intraepithelial 65 colorectal adenocarcinoma 65 thymoma 65 nodal metastasis 65 gastric carcinoma 65 astrocytoma 65 Glioblastoma Multiforme GBM 65 pancreatic carcinoma 65 mycosis fungoides 65 sonographic appearance 65 renal cell carcinomas 65 artery embolization 65 thyroid carcinoma 65 Squamous 65 osteoid osteoma 65 intraepithelial neoplasia 65 carcinoid tumor 65 intracranial tumors 65 benign neoplasms 65 lung pancreatic 65 leukoencephalopathy 65 bladder cancers 65 carcinoma HCC 65 renal tumors 65 ovarian malignancy 65 invasive ductal 65 ductal adenocarcinoma 65 ADPKD 65 acute myeloid 65 papillary 65 alveolar epithelial cells 65 sarcomatoid 65 hemorrhagic cystitis 65 LHRH receptor positive 65 esophageal gastric 65 thyrotoxicosis 65 percutaneous biopsy 65 T1a 64 biliary tract cancers 64 nasopharyngeal carcinoma 64 liposarcoma 64 prostate cancer PCa 64 skeletal metastases 64 bullous 64 meningeal 64 Duodenal 64 sclerosing 64 intraductal 64 ovarian carcinoma 64 malignant lymphomas 64 choriocarcinoma 64 parathyroid 64 hyperplastic 64 localized renal 64 endometrioid 64 allogeneic HSCT 64 hepatocellular cancer 64 adrenocortical cancer 64 polycythemia vera PV 64 metastatic malignant 64 tumoral 64 lung carcinomas 64 biliary tract cancer 64 vasogenic edema 64 pituitary adenomas 64 ANCA associated 64 endobronchial 64 lichen planus 64 pulmonary metastasis 64 malignant prostate 64 treat benign prostatic 64 precursor lesions 64 fibroadenomas 64 Hepatocellular Carcinoma HCC 64 malignant neoplasm 64 B Cell Lymphoma 64 thymic carcinoma 64 differentiated thyroid 64 basal cell carcinoma BCC 64 NSCLC tumors 64 hamartoma 64 Computed tomography 64 meningiomas 64 vulvar intraepithelial neoplasia 64 radiosensitivity 64 malignant lesions 64 metastatic carcinoma 64 lobular carcinoma 64 ASCUS 64 node metastases 64 neuroendocrine cancers 64 pT2 64 primary hyperparathyroidism 64 cisplatin chemotherapy 64 pheochromocytoma 64 Anaplastic 64 Candida infection 64 ovarian lung 64 transarterial 64 grade gliomas 64 esophagogastric junction 63 sinonasal 63 surgically resected 63 hypervascular tumors 63 neoplasms 63 artery stenosis 63 cell lymphoma ALCL 63 metastatic malignant melanoma 63 Gleevec resistant 63 lymphocytosis 63 nonmelanoma skin cancers 63 ductal cancer 63 pulmonary alveolar 63 antiangiogenic therapy 63 desmoplastic 63 necrotizing 63 pancreatic endocrine 63 Metastatic breast cancer 63 parathyroid carcinoma 63 Stomatitis 63 supratentorial 63 leukocytosis 63 prostate adenocarcinoma 63 FDG uptake 63 Glioblastoma multiforme 63 myofascial pain syndrome 63 nonmetastatic 63 erythema nodosum 63 malignant neoplasms 63 lymphocytic leukemia 63 Surgical resection 63 Mitomycin C 63 lymph node metastases 63 thrombocytosis 63 paraganglioma 63 leukemia AML 63 Cell Lymphoma 63 Glioblastoma Multiforme 63 cervical carcinoma 63 stereotactic radiotherapy 63 urothelial cancer 63 metastatic lung cancer 63 intestinal polyps 63 malignant pleural mesothelioma 63 gefitinib Iressa 63 atypical hemolytic uremic syndrome 63 Ribavirin causes 63 renal carcinoma 63 Adenocarcinoma 63 colorectal gastric 63 lymphocytic 63 intravesical therapy 63 cystic lesions 63 malignant lymphoma 63 fibrin deposition 63 Sezary syndrome 63 Histologically 63 resectable 63 invasive lobular 63 cholelithiasis 63 extracapsular extension 63 pyelonephritis 63 transfusion syndrome 63 recurrent glioblastoma multiforme 63 HBeAg negative 63 Chronic pancreatitis 63 myelodysplastic myeloproliferative diseases 63 unresectable tumors 63 HNSCC 63 FDG PET imaging 63 leiomyoma 63 metastatic neuroendocrine tumors 63 peritoneal cancer 63 chromosomal mutations 63 myelomas 63 diagnostic biomarker 63 pancreatic lung 63 CIN2 + 63 myelodysplastic syndrome MDS 63 follicular thyroid cancer 63 metastatic lymph nodes 63 schwannomas 63 castration resistant 63 adjuvant radiotherapy 63 PCNSL 62 breast pancreatic 62 tonsillar 62 cell carcinoma 62 breast carcinoma 62 somatostatin analogues 62 monocytic 62 cortical dysplasia 62 fibromatosis 62 HER2 positive cancers 62 Leydig cell 62 imatinib resistance 62 recurrent metastatic 62 malignant pancreatic 62 gallium nitrate 62 endometrial cancers 62 hepatorenal syndrome 62 baseline LDH 62 serous ovarian cancer 62 NMIBC 62 basal cell skin 62 SSc 62 sonographically 62 Wilms tumors 62 mesenteric 62 endocrine therapies 62 extracranial 62 conformal radiotherapy 62 Epstein Barr virus EBV 62 haematologic 62 recurrent NSCLC 62 colorectal neoplasms 62 bladder tumors 62 surgically resectable 62 intraepithelial 62 vestibular schwannomas 62 vasculopathy 62 adenocarcinomas 62 cytogenetic abnormalities 62 gastric cancers 62 total thyroidectomy 62 gadolinium enhanced 62 essential thrombocythemia 62 choroidal vasculopathy 62 anaplastic astrocytoma 62 atypical hyperplasia 62 oncogenic mutations 62 myeloproliferative disorder 62 obstructive coronary 62 papillary RCC 62 colorectal adenoma 62 neovascularisation 62 lung metastasis 62 Endometrial 62 completely resected 62 bronchoalveolar lavage 62 squamous cell carcinoma SCC 62 transesophageal echocardiography 62 lymphatic tissue 62 chemoradiotherapy 62 interstitial fibrosis 62 myeloproliferative 62 diagnostic modality 62 ductal breast cancer 62 transitional cell carcinoma 62 CYT# potent vascular disrupting 62 Squamous Cell Carcinoma 62 tumors GIST 62 benign polyps 62 dysplastic lesions 62 Hypotension 62 squamous cell lung cancer 62 embryonal rhabdomyosarcoma 62 seminoma 62 Hashimoto thyroiditis 62 receptor tyrosine kinase inhibitor 62 endometrial hyperplasia 62 epithelial ovarian 62 cisplatin resistant 62 gastrointestinal stromal tumors 62 monogenic 62 CIN3 62 BRAF V#E mutation 62 uterine tumors 62 mediastinitis 62 neurofibromas 62 angiographically 62 situ LCIS 62 KRAS oncogene 62 5alpha reductase 62 operable breast cancer 62 oesophagitis 62 Ductal carcinoma 62 node metastasis 62 imatinib Gleevec 62 pediatric malignancies 62 Cholangiocarcinoma 62 gastrointestinal stromal tumors GISTs 62 Enzastaurin 62 thyroid nodules 62 mesotheliomas 62 stage IIIA 62 teratoma 62 xenograft tumors 62 GORE TAG Device 62 complement inhibitor eculizumab 62 polyposis 62 esophagitis 62 pancytopenia 62 hypoperfusion 62 MYCN amplification 62 neoplastic 62 Toxicities 62 isoenzyme 62 gastrointestinal malignancies 62 ductal carcinomas 62 tumor histology 62 precancerous cervical lesions 62 arteritis 62 cytoreductive surgery 62 percutaneous drainage 62 radiographic findings 62 PAOD 62 gastric cardia 62 biliary strictures 62 stage IIIB 62 LVNC 62 Medullary thyroid cancer 61 refractory ovarian cancer 61 advanced adenoma 61 alveolar rhabdomyosarcoma 61 neuroblastomas 61 occlusive disease 61 primitive neuroectodermal tumor 61 transabdominal 61 hyperparathyroidism 61 Diffuse Large B 61 gemcitabine carboplatin 61 Surgical excision 61 metastatic ovarian cancer 61 arteriography 61 lymphomas leukemias 61 appendiceal 61 lymphoproliferative disorder 61 urethral stricture 61 taxane therapy 61 gastric carcinomas 61 situ CIS 61 pathologic examination 61 HER2 overexpression 61 N. gonorrhoeae 61 colorectal liver metastases 61 histologic subtype 61 pericardial effusion 61 anti angiogenic agents 61 histologically proven 61 precancerous condition 61 intrathoracic 61 candidemia 61 varices 61 prostate cancer CaP 61 MGd 61 biliary tract 61 denileukin diftitox 61 transthyretin amyloidosis 61 FOLFOX6 61 anemia thrombocytopenia 61 hematopoietic cancers 61 hepatocellular 61 variceal bleeding 61 interleukin IL -# 61 arteriovenous malformations 61 esophageal varices 61 premalignant 61 neurologic deficits 61 premalignant lesions 61 bronchogenic 61 MGUS 61 Myelodysplastic Syndrome MDS 61 pre cancerous lesion 61 methicillin susceptible Staphylococcus aureus 61 diabetes mellitus DM 61 carcinomatosis 61 renal scarring 61 #F FDG PET 61 mitochondrial toxicity 61 adenomatous polyps 61 recurrent glioblastoma 61 B7 H3 61 Systemic lupus erythematosus 61 synovial sarcoma 61 Waldenstrom macroglobulinemia 61 cytoreduction 61 serrated polyps 61 Vidaza azacitidine 61 Chronic lymphocytic leukemia 61 pancreatic ovarian 61 Leukemias 61 wedge resection 61 membranous nephropathy 61 gastrointestinal GI perforation 61 liposomal amphotericin B 61 choroidal neovascularization 61 hypereosinophilic syndrome 61 gastrointestinal stromal tumors GIST 61 peritumoral 61 cardiac troponin 61 gastroduodenal 61 hyperalgesia 61 osteosarcomas 61 CPVT 61 pediatric acute lymphoblastic 61 renal pelvis 61 ALK mutations 61 Chronic lymphocytic leukemia CLL 61 taxane resistant 61 SCCHN 61 bronchoalveolar 61 angiosarcoma 61 interstitial pneumonitis 61 immunohistochemical staining 61 ccRCC 61 castrate resistant 61 neoplasia CIN 61 metastatic basal cell 61 metastatic melanomas 61 Myelodysplastic Syndrome 61 idiopathic PAH 61 micrometastasis 61 neuroendocrine tumors 61 myeloproliferative disorders 61 squamous 61 EGF receptors 61 K ras mutations 61 QTc prolongation 61 renal biopsy 61 anogenital warts 61 clinicopathologic 61 paraneoplastic 61 BRCA deficient 61 transurethral resection 61 CP CPPS 61 needle aspiration 61 abacavir Ziagen 61 corticosteroid dexamethasone 61 sorafenib Nexavar 61 dasatinib Sprycel 61 Cryptococcus neoformans 61 basal cell cancers 61 Immunohistochemical staining 61 myelofibrosis polycythemia vera 61 nutlin 3a 61 gastrointestinal stromal tumor GIST 61 RAS mutations 61 gonococcal infection 61 Esophageal 61 hypointense 61 lung nodules 61 Histological examination 61 pleural fluid 61 GIST tumors 61 nephrogenic 61 endoscopic resection 61 chronic eosinophilic leukemia 61 neurological manifestations 61 Nephrogenic Systemic Fibrosis NSF 61 endometrial biopsy 61 herpesviruses 61 urethral strictures 61 cervical intraepithelial neoplasia 61 chemoembolization 61 pseudoaneurysm 61 ischemic colitis 61 intralesional 61 postoperative complication 61 endoscopic retrograde cholangiopancreatography ERCGrant Parpan 61 oligodendroglioma 61 malignant fibrous histiocytoma 61 Sjögren syndrome 61 invasive carcinomas 61 colorectal liver 61 chemo immunotherapy 61 hydronephrosis 61 intracerebral 61 recurrent bladder 61 pituitary tumors 61 serologic tests 61 squamous cell cancer 61 hepatic liver 61 FVIII inhibitors 61 intrahepatic 61 Nodules 61 HepDirect prodrug 61 eccrine 61 trophoblastic 60 histopathologic examination 60 tumorigenicity 60 HIPEC 60 transvaginal sonography 60 polycythemia vera essential thrombocythemia 60 chromophobe 60 lobular carcinomas 60 T1c 60 Legg Calvé Perthes disease 60 murine model 60 fibrous dysplasia 60 transthoracic 60 radiotherapy RT 60 eosinophilia 60 Basal cell 60 tumor lysis syndrome 60 hypophosphatemia 60 CMV retinitis 60 Eculizumab 60 systemic scleroderma 60 microsatellite instability 60 Naive Patients 60 locoregional 60 parenchymal 60 Aplidin 60 FluCAM arm 60 epididymitis 60 Histopathologic examination 60 Immunohistochemical analysis 60 hyperoxaluria 60 chemotherapy cisplatin 60 smoldering myeloma 60 HER2 amplification 60 Asymptomatic 60 ductal 60 trial evaluating PRX# 60 hepatocellular carcinoma HCC 60 Prostatic 60 squamous intraepithelial lesions 60 osteochondroma 60 malignant growths 60 atrophic gastritis 60 hyperplastic polyps 60 systemic amyloidosis 60 Hodgkin lymphoma HL 60 prognostic indicator 60 premalignant lesion 60 relapsed MM 60 lesional 60 thymectomy 60 Barrett esophagus BE 60 bone scintigraphy 60 hypervascular 60 gastroesophageal junction 60 pathologic diagnosis 60 hepatic toxicity 60 myeloid leukemia 60 Metastases 60 nonmelanoma 60 perioperatively 60 choroidal neovascularization CNV 60 IDH1 mutation 60 mutated KRAS 60 metastatic lesions 60 breast abscesses 60 keratoplasty 60 myeloproliferative diseases 60 leukemia ALL 60 Brain metastases 60 Dacogen decitabine 60 Langerhans cell histiocytosis 60 pheochromocytomas 60 Epstein Barr Virus EBV 60 osteoid 60 cardiac tamponade 60 GBMs 60 invasive ductal carcinoma 60 latent tuberculosis TB 60 SPECT CT imaging 60 spontaneous regression 60 intraoperative complications 60 superficial bladder cancer 60 chest radiographs 60 extramedullary 60 Recurrences 60 Chronic Myelogenous Leukemia CML 60 splenic 60 infection progressive multifocal 60 thyroid nodule 60 anti angiogenic therapy 60 MAGE A3 ASCI 60 invasive carcinoma 60 Gastric cancer 60 syngeneic 60 proliferative disorders 60 p# biomarker 60 Acute Myeloid Leukaemia AML 60 breast endometrial 60 leukemias lymphomas 60 epithelial cells lining 60 EUS FNA 60 nonalcoholic steatohepatitis NASH 60 hepatitis C viral infection 60 subependymal giant cell 60 Nasal polyps 60 gross hematuria 60 invasive candidiasis 60 Peripheral Arterial 60 Mesenchymal 60 postoperative delirium 60 bridging fibrosis 60 Zollinger Ellison Syndrome 60 thalidomide Thalomid 60 pemphigus vulgaris 60 suppurative 60 seminal vesicle 60 oligodendrogliomas 60 endometrial carcinoma 60 ganglion cysts 60 aplasia 60 eosinophilic inflammation 60 Human Papilloma 60 vaginal lesions 60 microvascular disease 60 antiphospholipid antibodies 60 testicular cancers 60 endoscopic ultrasonography 60 cytotoxic therapy 60 cell acute lymphoblastic 60 ultrasonographic examination 60 hepatic fibrosis 60 Fludara ® 60 polypoid 60 bladder ovarian 60 Carcinoid tumors 60 locoregional recurrence 60 chronic thromboembolic pulmonary 60 hepatic cirrhosis 60 orchitis 60 non resectable metastatic 60 resistant hormone refractory 60 calculi 60 Soft Tissue Sarcoma 60 recurrent glioblastoma multiforme GBM 60 preoperative diagnosis 60 lymphoid organs 60 Pemetrexed 60 hepatic lesions 60 carcinomas 60 trans retinoic acid 60 benign prostatic hyperplasia enlarged 60 spontaneously regress 60 Glioma 60 autoimmune pancreatitis 60 tyrosine kinase inhibitors TKIs 60 neuroblastoma tumors 60 hypertrophic scars 60 cryptococcal meningitis 60 metastatic uveal melanoma 60 cytologically 60 lymph node metastasis 60 Histologic 60 palliative radiotherapy 60 pancreatic NET 60 IV NSCLC 60 Neuroendocrine tumors 60 immunopathology 60 immunohistochemical analysis 60 uveal melanoma 60 etiologic agent 60 immunocompetent 60 esophagogastric 60 laparoscopically assisted 60 liposomal doxorubicin 60 metachronous 60 atherosclerotic lesions 60 bulbar 60 inotropic 60 opioid induced constipation OIC 60 tumor xenograft models 60 precancerous cervical 60 refractory prostate cancer 60 sonographically guided 60 carcinoma 60 p# deficient 60 lung adenocarcinomas 60 cholestasis 60 thrombotic complications 60 purpura 60 colorectal pancreatic 60 nonproliferative 60 Lenalidomide 60 Thymic 60 transplantation HCT 60 Multiple Myeloma MM 60 multisystem disease 60 clade B 60 neoplastic cells 60 infective endocarditis 60 colorectal lung 60 Brugada syndrome 60 arrhythmogenic right 60 esophageal squamous cell carcinoma 60 chronic lymphocytic 60 Carcinomas 60 denervation 60 temozolomide Temodar 60 sonographic diagnosis 60 Malignant mesothelioma 60 Squamous cell 60 pelvic irradiation 60 kidney urologic 60 erlotinib Tarceva 60 systemic anaplastic large 60 eosinophilic 60 colon carcinoma 60 Lyme arthritis 60 debulking surgery 60 nasopharyngeal cancer 60 neurological complications 60 heparin induced thrombocytopenia 60 pilocytic astrocytomas 60 intraperitoneal chemotherapy 60 histologic findings 60 florbetaben 60 liver scarring 60 hyperinsulinism 60 docetaxel Taxotere ® 60 histologic examination 60 EGFR mutation positive 59 pleural effusions 59 metastatic lesion 59 hyperacute 59 Intravenous immunoglobulin 59 Wegener granulomatosis 59 mucosal lesions 59 malignant transformation 59 Adjuvant chemotherapy 59 distant metastasis 59 anemias 59 autoimmune hemolytic anemia 59 follicular lymphomas 59 rFVIIa 59 biliary tree 59 biliary tract disease 59 pulmonary infiltrates 59 Deforolimus 59 urine cytology 59 torsade de pointes 59 essential thrombocythemia ET 59 bacteriuria 59 hepatic metastases 59 trophoblasts 59 neoplasia 59 Colon polyps 59 ZACTIMA 59 biopsy specimen 59 prostate ovarian 59 superficial basal cell carcinoma 59 fine needle aspiration 59 benign moles 59 choroidal 59 nodular melanoma 59 schwannoma 59 Hypertrophy 59 clinically detectable 59 vascular occlusion 59 preoperative chemotherapy 59 Sudhir Agrawal D.Phil 59 Glucocorticoids 59 alpha1 antitrypsin deficiency 59 monoclonal gammopathy 59 prolonged QT interval 59 hepatoma 59 keloid scarring 59 papillomatosis 59 autosomal dominant polycystic kidney 59 nonmalignant 59 multimodality therapy 59 Thal Dex 59 CTAP# Capsules 59 Cell Lymphoma CTCL 59 invasive lobular carcinoma 59 pancreatic prostate 59 ERBB2 59 non squamous NSCLC 59 anaplastic astrocytoma AA 59 cutaneous squamous cell carcinoma 59 LV dysfunction 59 granulomatous 59 pancreatic islet cell 59 juvenile idiopathic arthritis 59 concurrent chemoradiation 59 intracavitary 59 Chronic HCV 59 vesicoureteral reflux VUR 59 pDCs 59 underwent resection 59 Omacetaxine 59 pelvic lymphadenectomy 59 grade glioma 59 esophageal carcinoma 59 lymphoproliferative disorders 59 TTF Therapy 59 NF kB pathway 59 Urinary tract 59 apocrine 59 lung fibrosis 59 Metastatic 59 intra arterial chemotherapy 59 humanised monoclonal antibody 59 tumor necrosis 59 haematopoietic 59 DCIS ductal carcinoma 59 thyroid carcinomas 59 acute myocarditis 59 Upregulation 59 histologically confirmed 59 prostate bladder 59 Epstein Barr Virus 59 prostatic tissue 59 coronary artery blockages 59 monoclonal antibody conjugated 59 lipomas 59 postoperative chemotherapy 59 Gorlin syndrome 59 relapsing remitting MS RRMS 59 squamous cell 59 aneurysms AAA 59 aortic dissections 59 prophylactic cranial irradiation 59 bortezomib Velcade 59 NAVISTAR R 59 contralateral breast 59 MDCT angiography 59 small molecule tyrosine 59 cediranib 59 lobular 59 Lupus nephritis 59 non squamous 59 liver resection 59 fibrogenesis 59 Polycythemia 59 fibrosarcoma 59 venous malformations 59 veno occlusive disease 59 erlotinib Tarceva ® 59 pancreatic colon 59 enlarged spleens 59 radiochemotherapy 59 transcranial Doppler 59 bowel perforations 59 idiopathic myelofibrosis 59 penicillin allergy 59 nonischemic 59 mesothelial cells 59 autologous SCT 59 rebleeding 59 antiphospholipid syndrome 59 myeloid metaplasia 59 potent inducer 59 prognostic significance 59 Occlusive Disease 59 pT3 59 pDC 59 selective modulator 59 lobule 59 SOD2 gene 59 Moyamoya disease 59 smoldering multiple myeloma 59 AA Amyloidosis 59 posterior uveitis 59 Radical prostatectomy 59 MCF7 59 molecular abnormalities 59 hematological disorders 59 Mitoxantrone 59 tracheal intubation 59 acute lymphoblastic 59 chemo resistant 59 trastuzumab Herceptin ® 59 acute aortic dissection 59 pleural mesothelioma 59 lactate dehydrogenase LDH 59 murine models 59 Sjogren syndrome 59 immunomodulatory therapy 59 adrenalectomy 59 lymphoid tumors 59 cutaneous melanoma 59 hyperintensity 59 Pseudomonas aeruginosa infections 59 Radiofrequency ablation 59 urography 59 intracranial aneurysms 59 rituximab Rituxan 59 Eisenmenger syndrome 59 Estrogen Receptor 59 recombinant tissue plasminogen 59 retroperitoneal 59 thyroglobulin 59 telangiectasia 59 del 5q 59 malignancy 59 anterior uveitis 59 variceal hemorrhage 59 extrapulmonary 59 upper endoscopy 59 mycophenolate 59 Malignant Melanoma 59 Mycoplasma pneumoniae 59 ductal lavage 59 endocervical 59 cerebral angiography 59 proximal colon 59 lymphoma subtypes 59 TRAIL R1 59 CTAP# 59 adnexal mass 59 bone marrow suppression 59 normal karyotype 59 BrachySil TM 59 JMML 59 cytopenias 59 mesangial 59 hematoxylin eosin original 59 arthrography 59 penile cancers 59 neurofibroma 59 myxoid 59 indolent follicular non 59 axillary nodes 59 ELISPOT assay 59 pyogenic 59 PARP inhibition 59 tricuspid regurgitation 59 HGPIN 59 precancerous lesion 59 Atypical Hemolytic Uremic Syndrome 59 Glioblastoma multiforme GBM 59 Oesophageal 59 EGFR inhibitors 59 transcranial Doppler ultrasound 59 small lymphocytic lymphoma 59 histological subtypes 59 axillary lymph node 59 squamous cell cancers 59 Lymphoid 59 infiltrative 59 chronic granulomatous disease 59 gastrointestinal GI cancers 59 bladder prostate 59 pseudomembranous colitis 59 medically inoperable 59 bronchial epithelial cells 59 somatostatin receptors 59 lymphovascular invasion 59 medullary thyroid cancer 59 non resectable 59 antiproliferative effects 59 Xelox